Infectious diseases do not respect borders. An estimated 3 billion people in low-income countries across Africa, Asia and Latin America
Production, storage and distribution of COVID vaccine globally will be difficult and expensive
Harnessing a forgotten plague: Mathematical models suggest vaccine control of TB in hard hit countries
It has been a pandemic since at least biblical times, and unless effective strategies harness the global tuberculosis scourge, the
Pfizer to Seek Emergency Authorization for COVID-19 Vaccine
WEDNESDAY, Oct. 28, 2020 — In November, Pfizer plans to ask the U.S. Food and Drug Administration for emergency authorization
New vaccine tracker provides real-time updates on progress in developing a COVID-19 vaccine
McGill University professor Nicole Basta and her team have created an interactive online COVID-19 vaccine tracker, that provides real-time updates
AstraZeneca, J&J vaccine trials back on track in US
Two major clinical trials for experimental COVID-19 vaccines got back on track in the United States Friday—providing a glimmer of
Clinical trial for AstraZeneca/Oxford Covid-19 vaccine has resumed in US: company
The clinical trial for the COVID-19 vaccine being developed by AstraZeneca and Britain’s University of Oxford has resumed in the
Moderna’s COVID-19 vaccine won’t be ready by US election: report
US biotech firm Moderna won’t seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told
US will pay J&J $1billion for 100 million coronavirus vaccine doses
Trump administration will pay Johnson & Johnson $1billion in exchange for 100 million coronavirus vaccine doses The US government is
Another mRNA-based vaccine candidate protects animals against SARS-CoV-2
An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice
German govt pumps 300 mln euros into vaccine firm CureVac
Berlin will take a stake in German biotech company CureVac, Finance Minister Peter Altmaier said Monday, months after reports the